pizotifen
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 19, 2023 (NCT06158230)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
Serotonin receptor 2a and 2c (5HT2A and 5HT2C) antagonist
- Serotonin 2a (5-HT2a) receptorANTAGONIST
HTR2A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06500624 | N/A | Jun 3, 2024 | Riphah International University |
| NCT06158230 | Phase 2 | Mar 19, 2023 | Bangladesh Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bangladesh Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Riphah International University | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1